1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Clinical Trials of Drugs and Vaccines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Phase I 1.2.3 Phase II 1.2.4 Phase III 1.2.5 Phase IV 1.3 Market by Application 1.3.1 Global Clinical Trials of Drugs and Vaccines Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pharmaceutical Industry 1.3.3 Hospital 1.3.4 Laboratory 1.3.5 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Clinical Trials of Drugs and Vaccines Market Perspective (2016-2027) 2.2 Clinical Trials of Drugs and Vaccines Growth Trends by Regions 2.2.1 Clinical Trials of Drugs and Vaccines Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Clinical Trials of Drugs and Vaccines Historic Market Share by Regions (2016-2021) 2.2.3 Clinical Trials of Drugs and Vaccines Forecasted Market Size by Regions (2022-2027) 2.3 Clinical Trials of Drugs and Vaccines Industry Dynamic 2.3.1 Clinical Trials of Drugs and Vaccines Market Trends 2.3.2 Clinical Trials of Drugs and Vaccines Market Drivers 2.3.3 Clinical Trials of Drugs and Vaccines Market Challenges 2.3.4 Clinical Trials of Drugs and Vaccines Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Clinical Trials of Drugs and Vaccines Players by Revenue 3.1.1 Global Top Clinical Trials of Drugs and Vaccines Players by Revenue (2016-2021) 3.1.2 Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Players (2016-2021) 3.2 Global Clinical Trials of Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Clinical Trials of Drugs and Vaccines Revenue 3.4 Global Clinical Trials of Drugs and Vaccines Market Concentration Ratio 3.4.1 Global Clinical Trials of Drugs and Vaccines Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Clinical Trials of Drugs and Vaccines Revenue in 2020 3.5 Clinical Trials of Drugs and Vaccines Key Players Head office and Area Served 3.6 Key Players Clinical Trials of Drugs and Vaccines Product Solution and Service 3.7 Date of Enter into Clinical Trials of Drugs and Vaccines Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Clinical Trials of Drugs and Vaccines Breakdown Data by Type 4.1 Global Clinical Trials of Drugs and Vaccines Historic Market Size by Type (2016-2021) 4.2 Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Type (2022-2027) 5 Clinical Trials of Drugs and Vaccines Breakdown Data by Application 5.1 Global Clinical Trials of Drugs and Vaccines Historic Market Size by Application (2016-2021) 5.2 Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Clinical Trials of Drugs and Vaccines Market Size (2016-2027) 6.2 North America Clinical Trials of Drugs and Vaccines Market Size by Type 6.2.1 North America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) 6.2.2 North America Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) 6.2.3 North America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2027) 6.3 North America Clinical Trials of Drugs and Vaccines Market Size by Application 6.3.1 North America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) 6.3.2 North America Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) 6.3.3 North America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2027) 6.4 North America Clinical Trials of Drugs and Vaccines Market Size by Country 6.4.1 North America Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) 6.4.2 North America Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Clinical Trials of Drugs and Vaccines Market Size (2016-2027) 7.2 Europe Clinical Trials of Drugs and Vaccines Market Size by Type 7.2.1 Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) 7.2.2 Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) 7.2.3 Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2027) 7.3 Europe Clinical Trials of Drugs and Vaccines Market Size by Application 7.3.1 Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) 7.3.2 Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) 7.3.3 Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2027) 7.4 Europe Clinical Trials of Drugs and Vaccines Market Size by Country 7.4.1 Europe Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) 7.4.2 Europe Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size (2016-2027) 8.2 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type 8.2.1 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2027) 8.3 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application 8.3.1 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2027) 8.4 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Region 8.4.1 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Clinical Trials of Drugs and Vaccines Market Size (2016-2027) 9.2 Latin America Clinical Trials of Drugs and Vaccines Market Size by Type 9.2.1 Latin America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) 9.2.2 Latin America Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) 9.2.3 Latin America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2027) 9.3 Latin America Clinical Trials of Drugs and Vaccines Market Size by Application 9.3.1 Latin America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) 9.3.2 Latin America Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) 9.3.3 Latin America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2027) 9.4 Latin America Clinical Trials of Drugs and Vaccines Market Size by Country 9.4.1 Latin America Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) 9.4.2 Latin America Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size (2016-2027) 10.2 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type 10.2.1 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2027) 10.3 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application 10.3.1 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2027) 10.4 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Country 10.4.1 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Quintiles IMS 11.1.1 Quintiles IMS Company Details 11.1.2 Quintiles IMS Business Overview 11.1.3 Quintiles IMS Clinical Trials of Drugs and Vaccines Introduction 11.1.4 Quintiles IMS Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) 11.1.5 Quintiles IMS Recent Development 11.2 Paraxel International Corporation 11.2.1 Paraxel International Corporation Company Details 11.2.2 Paraxel International Corporation Business Overview 11.2.3 Paraxel International Corporation Clinical Trials of Drugs and Vaccines Introduction 11.2.4 Paraxel International Corporation Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) 11.2.5 Paraxel International Corporation Recent Development 11.3 Charles River Laboratories 11.3.1 Charles River Laboratories Company Details 11.3.2 Charles River Laboratories Business Overview 11.3.3 Charles River Laboratories Clinical Trials of Drugs and Vaccines Introduction 11.3.4 Charles River Laboratories Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) 11.3.5 Charles River Laboratories Recent Development 11.4 ICON Plc 11.4.1 ICON Plc Company Details 11.4.2 ICON Plc Business Overview 11.4.3 ICON Plc Clinical Trials of Drugs and Vaccines Introduction 11.4.4 ICON Plc Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) 11.4.5 ICON Plc Recent Development 11.5 SGS SA 11.5.1 SGS SA Company Details 11.5.2 SGS SA Business Overview 11.5.3 SGS SA Clinical Trials of Drugs and Vaccines Introduction 11.5.4 SGS SA Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) 11.5.5 SGS SA Recent Development 11.6 Pharmaceutical Product Development, LLC 11.6.1 Pharmaceutical Product Development, LLC Company Details 11.6.2 Pharmaceutical Product Development, LLC Business Overview 11.6.3 Pharmaceutical Product Development, LLC Clinical Trials of Drugs and Vaccines Introduction 11.6.4 Pharmaceutical Product Development, LLC Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) 11.6.5 Pharmaceutical Product Development, LLC Recent Development 11.7 Wuxi AppTec Inc. 11.7.1 Wuxi AppTec Inc. Company Details 11.7.2 Wuxi AppTec Inc. Business Overview 11.7.3 Wuxi AppTec Inc. Clinical Trials of Drugs and Vaccines Introduction 11.7.4 Wuxi AppTec Inc. Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) 11.7.5 Wuxi AppTec Inc. Recent Development 11.8 PRA Health Sciences 11.8.1 PRA Health Sciences Company Details 11.8.2 PRA Health Sciences Business Overview 11.8.3 PRA Health Sciences Clinical Trials of Drugs and Vaccines Introduction 11.8.4 PRA Health Sciences Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) 11.8.5 PRA Health Sciences Recent Development 11.9 Chiltern International Ltd. 11.9.1 Chiltern International Ltd. Company Details 11.9.2 Chiltern International Ltd. Business Overview 11.9.3 Chiltern International Ltd. Clinical Trials of Drugs and Vaccines Introduction 11.9.4 Chiltern International Ltd. Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) 11.9.5 Chiltern International Ltd. Recent Development 11.10 INC Research 11.10.1 INC Research Company Details 11.10.2 INC Research Business Overview 11.10.3 INC Research Clinical Trials of Drugs and Vaccines Introduction 11.10.4 INC Research Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) 11.10.5 INC Research Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Clinical Trials of Drugs and Vaccines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Phase I Table 3. Key Players of Phase II Table 4. Key Players of Phase III Table 5. Key Players of Phase IV Table 6. Global Clinical Trials of Drugs and Vaccines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Clinical Trials of Drugs and Vaccines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Clinical Trials of Drugs and Vaccines Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Clinical Trials of Drugs and Vaccines Market Share by Regions (2016-2021) Table 10. Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Clinical Trials of Drugs and Vaccines Market Share by Regions (2022-2027) Table 12. Clinical Trials of Drugs and Vaccines Market Trends Table 13. Clinical Trials of Drugs and Vaccines Market Drivers Table 14. Clinical Trials of Drugs and Vaccines Market Challenges Table 15. Clinical Trials of Drugs and Vaccines Market Restraints Table 16. Global Clinical Trials of Drugs and Vaccines Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Clinical Trials of Drugs and Vaccines Market Share by Players (2016-2021) Table 18. Global Top Clinical Trials of Drugs and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Trials of Drugs and Vaccines as of 2020) Table 19. Ranking of Global Top Clinical Trials of Drugs and Vaccines Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Clinical Trials of Drugs and Vaccines Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Clinical Trials of Drugs and Vaccines Product Solution and Service Table 23. Date of Enter into Clinical Trials of Drugs and Vaccines Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million) Table 26. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type (2016-2021) Table 27. Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Clinical Trials of Drugs and Vaccines Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Application (2016-2021) Table 31. Global Clinical Trials of Drugs and Vaccines Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million) Table 34. North America Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million) Table 36. North America Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size by Country (2022-2027) & (US$ Million) Table 63. Quintiles IMS Company Details Table 64. Quintiles IMS Business Overview Table 65. Quintiles IMS Clinical Trials of Drugs and Vaccines Product Table 66. Quintiles IMS Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million) Table 67. Quintiles IMS Recent Development Table 68. Paraxel International Corporation Company Details Table 69. Paraxel International Corporation Business Overview Table 70. Paraxel International Corporation Clinical Trials of Drugs and Vaccines Product Table 71. Paraxel International Corporation Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million) Table 72. Paraxel International Corporation Recent Development Table 73. Charles River Laboratories Company Details Table 74. Charles River Laboratories Business Overview Table 75. Charles River Laboratories Clinical Trials of Drugs and Vaccines Product Table 76. Charles River Laboratories Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million) Table 77. Charles River Laboratories Recent Development Table 78. ICON Plc Company Details Table 79. ICON Plc Business Overview Table 80. ICON Plc Clinical Trials of Drugs and Vaccines Product Table 81. ICON Plc Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million) Table 82. ICON Plc Recent Development Table 83. SGS SA Company Details Table 84. SGS SA Business Overview Table 85. SGS SA Clinical Trials of Drugs and Vaccines Product Table 86. SGS SA Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million) Table 87. SGS SA Recent Development Table 88. Pharmaceutical Product Development, LLC Company Details Table 89. Pharmaceutical Product Development, LLC Business Overview Table 90. Pharmaceutical Product Development, LLC Clinical Trials of Drugs and Vaccines Product Table 91. Pharmaceutical Product Development, LLC Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million) Table 92. Pharmaceutical Product Development, LLC Recent Development Table 93. Wuxi AppTec Inc. Company Details Table 94. Wuxi AppTec Inc. Business Overview Table 95. Wuxi AppTec Inc. Clinical Trials of Drugs and Vaccines Product Table 96. Wuxi AppTec Inc. Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million) Table 97. Wuxi AppTec Inc. Recent Development Table 98. PRA Health Sciences Company Details Table 99. PRA Health Sciences Business Overview Table 100. PRA Health Sciences Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million) Table 101. PRA Health Sciences Recent Development Table 102. Chiltern International Ltd. Company Details Table 103. Chiltern International Ltd. Business Overview Table 104. Chiltern International Ltd. Clinical Trials of Drugs and Vaccines Product Table 105. Chiltern International Ltd. Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million) Table 106. Chiltern International Ltd. Recent Development Table 107. INC Research Company Details Table 108. INC Research Business Overview Table 109. INC Research Clinical Trials of Drugs and Vaccines Product Table 110. INC Research Revenue in Clinical Trials of Drugs and Vaccines Business (2016-2021) & (US$ Million) Table 111. INC Research Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Clinical Trials of Drugs and Vaccines Market Share by Type: 2020 VS 2027 Figure 2. Phase I Features Figure 3. Phase II Features Figure 4. Phase III Features Figure 5. Phase IV Features Figure 6. Global Clinical Trials of Drugs and Vaccines Market Share by Application: 2020 VS 2027 Figure 7. Pharmaceutical Industry Case Studies Figure 8. Hospital Case Studies Figure 9. Laboratory Case Studies Figure 10. Other Case Studies Figure 11. Clinical Trials of Drugs and Vaccines Report Years Considered Figure 12. Global Clinical Trials of Drugs and Vaccines Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Clinical Trials of Drugs and Vaccines Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Clinical Trials of Drugs and Vaccines Market Share by Regions: 2020 VS 2027 Figure 15. Global Clinical Trials of Drugs and Vaccines Market Share by Regions (2022-2027) Figure 16. Global Clinical Trials of Drugs and Vaccines Market Share by Players in 2020 Figure 17. Global Top Clinical Trials of Drugs and Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Trials of Drugs and Vaccines as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Clinical Trials of Drugs and Vaccines Revenue in 2020 Figure 19. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type (2016-2021) Figure 20. Global Clinical Trials of Drugs and Vaccines Revenue Market Share by Type (2022-2027) Figure 21. North America Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Clinical Trials of Drugs and Vaccines Market Share by Type (2016-2027) Figure 23. North America Clinical Trials of Drugs and Vaccines Market Share by Application (2016-2027) Figure 24. North America Clinical Trials of Drugs and Vaccines Market Share by Country (2016-2027) Figure 25. United States Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Clinical Trials of Drugs and Vaccines Market Share by Type (2016-2027) Figure 29. Europe Clinical Trials of Drugs and Vaccines Market Share by Application (2016-2027) Figure 30. Europe Clinical Trials of Drugs and Vaccines Market Share by Country (2016-2027) Figure 31. Germany Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Share by Type (2016-2027) Figure 39. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Share by Application (2016-2027) Figure 40. Asia-Pacific Clinical Trials of Drugs and Vaccines Market Share by Region (2016-2027) Figure 41. China Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Clinical Trials of Drugs and Vaccines Market Share by Type (2016-2027) Figure 49. Latin America Clinical Trials of Drugs and Vaccines Market Share by Application (2016-2027) Figure 50. Latin America Clinical Trials of Drugs and Vaccines Market Share by Country (2016-2027) Figure 51. Mexico Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Share by Type (2016-2027) Figure 55. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Share by Application (2016-2027) Figure 56. Middle East & Africa Clinical Trials of Drugs and Vaccines Market Share by Country (2016-2027) Figure 57. Turkey Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Clinical Trials of Drugs and Vaccines Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Quintiles IMS Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021) Figure 61. Paraxel International Corporation Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021) Figure 62. Charles River Laboratories Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021) Figure 63. ICON Plc Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021) Figure 64. SGS SA Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021) Figure 65. Pharmaceutical Product Development, LLC Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021) Figure 66. Wuxi AppTec Inc. Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021) Figure 67. PRA Health Sciences Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021) Figure 68. Chiltern International Ltd. Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021) Figure 69. INC Research Revenue Growth Rate in Clinical Trials of Drugs and Vaccines Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Quintiles IMS Paraxel International Corporation Charles River Laboratories ICON Plc SGS SA Pharmaceutical Product Development, LLC Wuxi AppTec Inc. PRA Health Sciences Chiltern International Ltd. INC Research